Catabasis Pharmaceuticals completes follow-on

Catabasis Pharmaceuticals Inc. (NASDAQ:CATB), Cambridge, Mass. Business: Endocrine/Metabolic, Autoimmune, Neurology Date completed: 2016-09-23 Type: Follow-on Raised: $11.5 million Shares: 2.9 million...